The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis
- 1 October 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 155 (1-2) , 57-67
- https://doi.org/10.1016/0014-2999(88)90402-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Effect of the Thromboxane Receptor Antagonist SQ 29,548 on Myocardial Infarct Size in DogsJournal of Cardiovascular Pharmacology, 1988
- Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog.Circulation Research, 1987
- Cardioprotective Actions of Specific Thromboxane Receptor Antagonist in Acute Myocardial IschemiaJournal of Cardiovascular Pharmacology, 1987
- Anti-ischemic actions of a new throm☐ane receptor antagonist during acute myocardial ischemia in catsAmerican Heart Journal, 1985
- Neutrophil Depletion Suppresses 111In-Labeled Platelet Accumulation in Infarcted MyocardiumJournal of Cardiovascular Pharmacology, 1985
- Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.Circulation Research, 1984
- Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.Published by Wiley ,1983
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Measurement of chemiluminescence in freshly drawn human bloodJournal of Molecular Medicine, 1981
- Ultrastructural damage associated with reoxygenation of the anoxic myocardiumJournal of Molecular and Cellular Cardiology, 1975